ABBV vs PYPL: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and PayPal Holdings, Inc. β fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
AbbVie Inc. Β· Healthcare
$197.69
+11.0% upside to fair value
Grade C
High Quality
VS
PayPal Holdings, Inc. Β· Financial Services
$50.39
+110.0% upside to fair value
Grade B
QuantHub Verdict
PYPL has more upside to fair value
(+110.0%).
PYPL trades at a lower forward P/E
(9.0x).
These are model outputs β not personalized investment advice.
See all research β
Valuation & Fundamentals
| Metric |
ABBV |
PYPL |
| Current Price |
$197.69 |
$50.39 |
| Fair Value Estimate |
$219.51 |
$105.84 |
| Upside to Fair Value |
+11.0%
|
+110.0%
|
| Market Cap |
$349.7B |
$45.3B |
| Forward P/E |
83.3x
|
9.0x
|
| EV / EBITDA |
23.4x
|
6.1x
|
| Price / Sales |
5.7x
|
1.4x
|
| Price / FCF |
18.7x
|
8.2x
|
| Revenue Growth YoY |
+10.0%
|
+3.7%
|
| Gross Margin |
70.2%
|
46.6%
|
| Operating Margin |
26.7%
|
18.3%
|
| Return on Equity |
-361.6%
|
25.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.35%
|
12.27%
|
| Analyst Consensus |
Strong Buy
|
Sell
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwaβ¦
PayPal Holdings, Inc. operates as a leading digital payments platform offering transaction processing and value-added financial services such as consumer credit and BNPL products. The business quality is medium due to a narrowing competitive moat amid increasing pressure from big tech competitors and slowing growth in its core branded checkout segment. The stock is currently mispriced and cheap, β¦
Accumulation Zones
| Metric |
ABBV |
PYPL |
| Zone Low |
$164.63 |
$79.38 |
| Zone High |
$186.58 |
$89.96 |
| In Buy Zone? |
No
|
Yes
|